FindTrial
Sign In

Observation of ciprofol in bronchoscopy

Observing the effectiveness and safety of ciprofol in bronchoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071508
Enrollment
Unknown
Registered
2023-05-17
Start date
2023-05-17
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchoscopy

Interventions

the elderly group:only observation and statistics
the middle-aged group:only observation and statistics

Sponsors

The Third People’s Hospital of Changzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: the elderly and middle-aged patients who used ciprofol for bronchoscopy in the Third People's Hospital of Changzhou between February 2023 to May 2023.

Exclusion criteria

Exclusion criteria: Patients with severe hemoptysis and airway stenosis.

Design outcomes

Primary

MeasureTime frame
the effective concentration;—

Secondary

MeasureTime frame
SBP;HR;DBP;—

Countries

China

Contacts

Public ContactWeibin Xie

The Third People’s Hospital of Changzhou

xiewb2010@163.com+86 133 0611 7987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026